UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000017722
Receipt No. R000018175
Official scientific title of the study Observation of the upper gastrointestinal tract lesions by epinephrine spraying
Date of disclosure of the study information 2015/05/28
Last modified on 2018/12/10 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Observation of the upper gastrointestinal tract lesions by epinephrine spraying
Title of the study (Brief title) Observation of lesions by epinephrine spraying
Region
Japan

Condition
Condition esophageal cancer, gastric cancer
Classification by specialty
Gastroenterology Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Consider the endoscopic image of the change by vasoactive substances in esophageal/ gastric mucosa or vessel in mucosa
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Contribution to diagnoses of extent and depth of cancer lesions
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Other
Interventions/Control_1 At upper gastrointestinal endoscopy examination,in addition to the standard diagoses, epinephrine spraying is performed
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with the upper gastrointestinal tract lesions will be enforced the treatment (surgery or endoscopic therapy)
Key exclusion criteria The patients who are allergic to epinephrine
Other, patients judged to be inappropriate
Target sample size 50

Research contact person
Name of lead principal investigator Kawakubo Hirofumi
Organization Keio University,School of Medicine
Division name Surgery
Address Shinanomachi 35,Shinjyuku-ku,Tokyo
TEL 03-3353-1211
Email hkawakubo@z3.keio.jp

Public contact
Name of contact person Rieko Nakamura
Organization Keio University,School of Medicine
Division name Surgery
Address Shinanomachi 35,Shinjyuku-ku,Tokyo
TEL 03-3353-1211
Homepage URL
Email rieko-na@cam.hi-ho.ne.jp

Sponsor
Institute Keio University,School of Medicine
Institute
Department

Funding Source
Organization Keio University,School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 05 Month 28 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 09 Month 15 Day
Anticipated trial start date
2014 Year 11 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 05 Month 28 Day
Last modified on
2018 Year 12 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018175